ArticleCancers2024

Silmitasertib (CX-4945) Disrupts ERα/HSP90 Interaction and Drives Proteolysis through the Disruption of CK2β Function in Breast Cancer Cells.

Hogyoung Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.